Tesis
Análises dos dados clínicos e marcadores celulares nas respostas TH1 e TH2 nas diferentes formas clínicas de pacientes com hanseníase
Fecha
2017-03-10Registro en:
RODRIGUES, Ricardo Wilson de Pinho. Análises dos dados clínicos e marcadores celulares nas respostas TH1 e TH2 nas diferentes formas clínicas de pacientes com hanseníase. 2017. 51 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal de Mato Grosso, Faculdade de Medicina, Cuiabá, 2017.
Autor
Damazo, Amílcar Sabino
http://lattes.cnpq.br/3708368867452889
Damazo, Amílcar Sabino
165.559.138-00
http://lattes.cnpq.br/3708368867452889
Albuquerque, Deijanira Alves de
123.859.993-15
http://lattes.cnpq.br/5899815802293762
165.559.138-00
Santos, Rogério Alexandre Nunes dos
027.312.254-16
http://lattes.cnpq.br/8059360077629644
Vieira, Evanice Menezes Marçal
062.035.088-10
http://lattes.cnpq.br/8227577152556293
Porto, Alessandra Nogueira
694.377.691-68
http://lattes.cnpq.br/7504802823315527
Institución
Resumen
There are currently no laboratory tests or even sensitive and effective tests for the early diagnosis of
leprosy. The aim of this study was to analyze the clinical characteristics of patients with leprosy and
investigate their immunological profile, comparing this with the type of lesion and the presence or
absence of scar for BCG vaccine. Statistical analyzes were performed by employing comparative
tests (Pearson´s chi-square) to evaluate the variables in different clinical forms, considering 5% of
significance level. The results there was emphasis on: Patients from 34 to 53 years in VV clinical
form (26.9%); Caucasians in BT clinical form (42.0%); predominance of male in the BV clinical
forms (19.0%) and VV (26.9%); presence of scar BCG vaccine with a predominance in the BT
clinical form (27.5%); nerves more affected with predominance in the lower limbs in BT clinical
form (38%). Significant differences occurred in: lesions with hypochromic predominance in BT
clinical form (24.0%); type of lesion with difuse predominance in TT clinical form (28.0%); border
of the lesion that is ill-defined dominance in VV clinical form (30.0%); limit of lesion with irregular
predominance in VV clinical form (32.0%); immunoreactivity with Th1 predominance in the BT
clinical form (41.7%). We conclude that the evaluation of the immunological profile in leprosy
patients may contribute to the more detailed diagnosis and possibly with better characterization of
prognosis for these individuals.